HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,279,890 | +2.3% | 112,039 | -3.4% | 0.04% | +7.7% |
| Q2 2023 | $4,182,028 | -9.7% | 115,942 | -4.4% | 0.04% | -15.2% |
| Q1 2023 | $4,630,881 | +89437.5% | 121,259 | +33.4% | 0.05% | -41.0% |
| Q4 2022 | $5,172 | -99.9% | 90,902 | -8.3% | 0.08% | +23.8% |
| Q3 2022 | $3,918,000 | -11.0% | 99,089 | -0.9% | 0.06% | -10.0% |
| Q2 2022 | $4,402,000 | +10.6% | 100,039 | +0.2% | 0.07% | +29.6% |
| Q1 2022 | $3,980,000 | -2.5% | 99,811 | -1.7% | 0.05% | +8.0% |
| Q4 2021 | $4,081,000 | -4.7% | 101,496 | -3.6% | 0.05% | -5.7% |
| Q3 2021 | $4,283,000 | -5.4% | 105,290 | +5.6% | 0.05% | 0.0% |
| Q2 2021 | $4,529,000 | +14.3% | 99,743 | +5.0% | 0.05% | +8.2% |
| Q1 2021 | $3,961,000 | -9.1% | 95,000 | -6.9% | 0.05% | -10.9% |
| Q4 2020 | $4,358,000 | – | 102,033 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |